Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.78

+$0.03 (+1.71%)

Nov 2, 2026, 9:45 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $88.73M

Enterprise Value $75.69M

Beta -8.91

Average Volume 72.51K

Shares Outstanding (Diluted) 48.28M

Shares Change YoY -74.51%

Institutional Ownership 4.54%

Exchange NASDAQ

ISIN US73110F1003

Price Performance

Price Change 1M -14.4%

Price Change 3M -18.7%

Price Change 6M -65.2%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -14.2%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -98.3%

Valuation

PE Ratio -14.58

Forward PE N/A

PEG Ratio 0.17

Forward PEG -0.44

PS Ratio N/A

Forward PS N/A

PB Ratio 7.97

P/FCF Ratio -15.02

P/Adj. FCF Ratio -13.66

P/OCF Ratio -14.58

EV/Sales N/A

EV/EBIT -11.05

EV/EBITDA -11.05

EV/FCF -13.03

Earnings Yield -6.9%

FCF Yield -6.7%

Adj. FCF Yield -7.3%

Financial Health

Net Cash $11.54M

Total Debt $0

Cash & Short-Term Investments $11.54M

Total Assets $11.81M

Current Ratio 13.53

Quick Ratio 13.53

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 46.88

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -9.9%

Returns

Return on Assets -58.0%

Return on Equity -117.6%

Return on Invested Capital -47.8%

Return on Capital Employed -47.8%

Return on Tangible Assets -58.0%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -38.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.06

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $6.50

Price Target Upside 271.4%

Cash Flow

Operating Cash Flow $-5.81M

Free Cash Flow $-5.81M

Adj. Free Cash Flow $-6.38M

FCF Per Share -$0.12

OCF Per Share -$0.12

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-5.22M

EBITDA $-6.85M

Net Income $-6.85M

EPS (Diluted) -$0.12

Revenue / Employee N/A

Profit / Employee $-622.64K

Employees 11